It has a plasma elimination half-life of 12 hours and has been administered in a twice-daily dosing ... apixaban plus antiplatelet monotherapy or dual-antiplatelet therapy in patients with acute ...

The efficacy and safety of apixaban for VTE prophylaxis in major orthopedic surgery have been evaluated in one Phase II trial and three Phase III trials. Traditional treatment of acute VTE entails ...